industry session programmes - geneva 2017 · industry session programmes 26th eadv congress . 2...

INDUSTRY SESSION PROGRAMMES

26TH

EADV Congress

2

TABLE OF CONTENT

REGULATIONS RELATED TO INDUSTRY ACTIVITIES ................................................................. 4

Promotion of medicinal products ................................................................................................... 4

Exhibition area & industry session access ..................................................................................... 4

Advertising .................................................................................................................................... 4

Thursday, 14 September 2017 - SATELLITE SYMPOSIA

SAT01: Boehringer Ingelheim .................................................................................................... 5

SAT02: AbbVie .......................................................................................................................... 5

SAT03: Janssen PEARLS .......................................................................................................... 6

SAT04: Sanofi Genzyme and Regeneron .................................................................................. 6

SAT05: Novartis ......................................................................................................................... 7

SAT06: Pfizer ............................................................................................................................. 7

SAT07: A-DERMA ..................................................................................................................... 8

SAT08: Medac ........................................................................................................................... 8

SAT09: AVENE .......................................................................................................................... 9

SAT10: Celgene ........................................................................................................................ 9

SAT11: LEO Pharma ............................................................................................................... 10

SAT12: Almirall ........................................................................................................................ 10

Friday, 15 September 2017 - SATELLITE SYMPOSIA

SAT13: Integritas ..................................................................................................................... 11

SAT14: PeerVoice ................................................................................................................... 11

SAT15: LEO Pharma ............................................................................................................... 12

SAT16: Sandoz ........................................................................................................................ 12

SAT17: International Psoriasis Council .................................................................................... 13

SAT18: Clinique ....................................................................................................................... 13

SAT19: epgonline.org .............................................................................................................. 14

SAT20: Medscape Education ................................................................................................... 14

SAT21: Janssen PEARLS ........................................................................................................ 15

SAT22: Almirall ........................................................................................................................ 15

3

Thursday, 14 September 2017 - MEET-THE-EXPERT

MTE01: Jett Medical ................................................................................................................ 16

MTE02: Fotona Medical Lasers ............................................................................................... 16

MTE07: LEO Pharma South Asia ............................................................................................. 16

MTE08: Japan Bio Products co., ltd ......................................................................................... 16

Friday, 15 September 2017 - MEET-THE-EXPERT

MTE03: Cynosure .................................................................................................................... 17

MTE04: LEO Pharma South Asia ............................................................................................. 17

MTE05: Celgene ...................................................................................................................... 17

MTE06: CoolSculpting ............................................................................................................. 17

4

REGULATIONS RELATED TO INDUSTRY ACTIVITIES

PROMOTION OF MEDICINAL PRODUCTS

According to the Swiss Federal Act on Medicinal Products and Medical Devices (Therapeutic Products Act,

TPA) of 15 December 2000 (Status as of 1 January 2014) based on Article 95 paragraph 1 and Article 118

paragraph 2 of the Federal Constitution, and having considered the Federal Council Dispatch dated 1 March

1999, the advertising of all types of medicinal products should be directed exclusively at persons who are able

to prescribe or dispense them.

As the event will take place in Geneva, Switzerland, and a multidisciplinary audience will be attending the 26th

EADV Congress, the EADV will assign different badges to Healthcare Professionals (HCP) and NON-

Healthcare Professionals (NON-HCP) to ensure compliance with the above regulations.

The Code of Conduct of the Pharmaceutical Industry in Switzerland of December 4, 2003, revised on

September 6, 2013 (As per: 1 November, 2014) defines Healthcare Professionals as:

“Physicians, dentists and pharmacists who are working in particular in a practice or hospital, together with

pharmacists active in retail businesses, and persons who are authorised by Swiss law on therapeutic

products, to prescribe, deliver or use prescription-only medicinal products for humans.”

EXHIBITION AREA & INDUSTRY SESSION ACCESS

Access to the industry Exhibition area will be restricted to Healthcare Professionals (HCP) as described

above. In addition, Satellite Symposia and Meet-the-Expert sessions presenting data or research of

prescription medicines will be limited exclusively to Healthcare Professionals (HCP) only.

Students, Press and Patient Organisation Representatives will not be permitted entry to the exhibition area,

satellite symposia and meet-the-expert sessions, and will automatically be classified as NON-Healthcare

Professionals.

ADVERTISING

Satellite Symposia and Meet-the-Expert sessions presenting data on the development, research or other

issues related to prescription medicine will be restricted to Healthcare Professionals and Industry staff only. All

promotional flyers and marketing ads related to these industry sessions should be strictly limited to HCPs only.

Delegate badges will be controlled before entry into these sessions.

5

Thursday, 14 September 2017 SATELLITE SYMPOSIA

SAT01 Boehringer Ingelheim (HCPs only)

How will we manage psoriasis - in 2037?

17:00-18:30 Room 2

Chair: Jonathan Barker (London, United Kingdom)

SAT01.01 17:00 Introduction

Jonathan Barker (London, United Kingdom)

SAT01.02 17:05 Which new scientific advances will our patients benefit from in 2037?

Followed by moderated panel discussion

Michel Gilliet (Lausanne, Switzerland)

SAT01.03 17:30 How will physicians and patients interact in 2037?


Marie Ennis-O’Connor (Dublin, Ireland)

SAT01.04 18:00 How can the modification of lifestyle control the immune system in 2037?


Fulvio D'Acquisto (London, United Kingdom)

SAT01.05 18:25 Summary and close

Jonathan Barker (London, United Kingdom)

SAT02 AbbVie (HCPs only)

The PsoNetwork: The future of Psoriasis Management

17:00-18:30 Room 3

Chair: Diamant Thaçi (Lübeck, Germany)

SAT02.01 17:00 Welcome to PsoNetwork

Diamant Thaçi (Lübeck, Germany)

SAT02.02 17:08 Meeting patients’ needs beyond the skin

Patients’ voices (Video)

SAT02.03 17:12 The inflammatory kaleidoscope of psoriatic disease - what does it mean

for integrated care?


SAT02.04 17:30 On the PsoNetwork: Perspectives of the multidisciplinary team


Johan De Sutter (Ghent, Belgium)

Peter Irving (London, United Kingdom)

SAT02.05 18:05 PsO Cosmos: Audience views and questions

All

SAT02.06 18:15 Tomorrow’s world: The future of care for psoriatic disease


SAT02.07 18:25 Close and final credits


6


SAT03 Janssen PEARLS (HCP only)

IL-23 in psoriasis: Integrating new therapies in the

current treatment landscape

17:00-18:30 Room 4

Chair: Andrew Blauvelt (Portland, USA)

Kristian Reich (Hamburg, Germany)

SAT03.01 17:00 Welcome and introduction


SAT03.02 17:05 An immunological understanding of cytokine pathways in

psoriasis

Andrew Blauvelt (Portland, USA)

SAT03.03 17:25 The clinical value of IL-23 inhibitors


SAT03.04 17:45 Embedding emerging treatments into the current therapeutic

environment

Giampiero Girolomoni (Verona, Italy)

SAT03.05 18:05 Interactive Q&A and discussion

All

SAT03.06 18:25 Conclusions and closing remarks


SAT04 Sanofi Genzyme and Regeneron (HCP only)

Atopic Dermatitis: Perspectives From Patients and

Clinicians

17:00-18:30 Room A&B

SAT04.01 17:00 The Burden of Disease in Patients With Atopic Dermatitis:

Comorbidities and Beyond

Lawrence Eichenfield (San Diego, USA)

SAT04.02 17:20 Current Therapies and Clinical Challenges in the

Management of Atopic Dermatitis

Stephan Weidinger (Kiel, Germany)

SAT04.03 17:40 Building on Recent Advances in Pathophysiology: Emerging

Therapies for Atopic Dermatitis

Eric Simpson (Portland, USA)

SAT04.04 18:00 Patient and Physician Perspectives on Atopic Dermatitis:

Guided patient and physician dialogue

Michael J. Cork (Sheffield, United Kingdom)

SAT04.05 18:20 Closing Remarks and Panel Q&A

All

7


SAT05 Novartis (HCP only)

Early Intervention and Disease Modification: Next Steps in

Psoriasis

17:00-18:30 Room C


Richard Langley (Nova Scotia, Canada)

SAT05.02 17:05 Building on a strong foundation: Long-term experience


SAT05.03 17:25 The Psoriasis Mosaic - Psoriatic Arthritis and Joint Damage

Bruce Kirkham (London, United Kingdom)

SAT05.04 17:45 New Dimensions: Early Intervention and Disease Modification

Lars Iversen (Aarhus, Denmark)

SAT05.05 18:05 Discussion, Q&A

All

SAT05.06 18:20 Meeting close


SAT06 Pfizer (HCP only)

Atopic dermatitis: more than an itch

17:00-18:30 Room E

Chair: Thomas Bieber (Bonn, Germany)

SAT06.01 17:00 Chair welcome and introduction

Thomas Bieber (Bonn, Germany)

SAT06.02 17:05 Atopic dermatitis: is there more than meets the eye?

Michael Cork (Sheffield, United Kingdom)

SAT06.03 17:30 Are we just scratching the surface with current management?


SAT06.04 17:55 Could new approaches ease disease burden?

Amy Paller (Chicago, Illinois, USA)

SAT06.05 18:15 Discussion and close


8


SAT07 A-DERMA (Open to all)

Topical and Systemic Treatment Options for Atopic

Dermatitis at the Edge of the Biological Revolution

17:00-18:30 Room F

Chair: Andreas Wollenberg (Munich, Germany)


Andreas Wollenberg (Munich, Germany)

SAT07.02 17:05 Multimodal Management of severe AD before and after the

introduction of Biologicals


SAT07.03 17:20 Reactive and Proactive Therapy of moderate AD

Christian Vestergaard (Aarhus, Danemark)

SAT07.04 17:35 News in prevention of atopic dermatitis. Early intervention

therapy of mild AD

Sebastien Barbarot (Nantes, France)

SAT07.05 17:50 Clinical cases

Antonio Torrelo (Madrid, Spain)

SAT07.06 18:05 What’s new: Focus on transcriptomic study and clinical study

in newborns with emollient based on Rhealba Oat

Audrey Nosbaum (Lyon, France)

SAT07.07 18:20 Q&A. Conclusion & Take‐home message.


SAT08 Medac (HCP only)

Safety and efficacy of subcutaneous methotrexate in psoriasis

therapy - METOP study data

17:00-18:30 Room G

Chair: Richard Warren (Manchester, United Kingdom)


Richard Warren (Manchester, United Kingdom)

SAT08.02 17:05 Use of subcutaneous methotrexate in the therapy of psoriasis

patients

Denis Jullien (Lyon, France)

SAT08.03 17:30 METOP clinical trial data using subcutaneous methotrexate in

treatment of psoriasis: Long-term benefits for patients


SAT08.04 17:55 Development of a psoriasis therapy cost model focusing on the UK

Martin O’Leary (London, United Kingdom)

SAT08.05 18:20 Discussion and summary


9


SAT09 AVENE (Open to all)

Advances in Acne : intimate mechanisms of long term

remission and the dermo-cosmetic management of acne

17:00-18:30 Room K

Chair: Jean-Hilaire Saurat (Geneva, Switzerland)

SAT09.01 17:00 Strategic targets in acne: the microcomedone in question

Jean-Hilaire Saurat (Geneva, Switzerland)

SAT09.02 17:30 The modulation of sebogenesis as a strategy to prevent acne

evolution

Mauro Picardo (Rome, Italy)

SAT09.03 18:00 Triacneal Expert in clinical practice: an update

Victor Georgescu (Lavaur, France)

SAT10 Celgene (HCP only)

A comprehensive approach to psoriasis: Understanding

meaningful improvement in clinical practice

17:00-18:30 Room V

Chair: Matthias Augustin (Hamburg, Germany)

SAT10.01 17:00 Opening statement

Matthias Augustin (Hamburg, Germany)

SAT10.02 17:05 A multi-faceted, systemic condition: Are we treating all aspects

of psoriatic disease?

Hervé Bachelez (Paris, France)

Audience Q&A

SAT10.03 17:30 Defining treatment goals in psoriasis: Are we listening to our

patients?


Audience Q&A

SAT10.04 17:55 Case studies from the clinic: Meeting clinical and patient goals

Mark Goodfield (Leeds, United Kingdom)

Audience Q&A

SAT10.05 18:20 Closing statement


10


SAT11 LEO Pharma (HCP only)

Innovation that drives your dermatological future

17:00-18:30 Room W

Chair: Bernd Bonnekoh (Magdeburg, Germany)


Bernd Bonnekoh (Magdeburg, Germany)

SAT11.02 17:05 Forward thinking: be prepared how future trends will impact your

dermatological practice

Jorge Juan Fernandez (Barcelona, Spain)

SAT11.03 17:30 Reasons to apply topical formulation innovation in psoriasis

Christian Surber (Basel, Switzerland)

SAT11.04 17:45 Why managing itch & psychosocial co-morbidities experienced by patients

with psoriasis is so important

Anthony Bewley (London, United Kingdom)

SAT11.05 18:00 Taking control over psoriasis: from flare-up to pro-active management


SAT11.06 18:15 Take home messages: what drives your dermatological future


Jorge Juan Fernandez (Barcelona, Spain)

SAT12 Almirall (HCP only)

The Changing Landscape of Psoriasis: New Horizons for Oral

Therapies

17:00-18:30 Room X

Chair: Wolf-Henning Boehncke (Geneva, Switzerland)

SAT12.01 17:00 Welcome & Introductions

Wolf-Henning Boehncke (Geneva, Switzerland)

SAT12.02 17:05 Unmet needs in moderate to severe psoriasis


SAT12.03 17:15 Experience & new data with the use of FAEs in the treatment of psoriasis

Ulrich Mrowietz (Kiel, Germany)

SAT12.04 17:40 Practical clinical tips on managing treatment with FAEs

Peter Weisenseel (Hamburg, Germany)

SAT12.05 18:05 Round table



Peter Weisenseel (Hamburg, Germany)

Luigi Naldi (Bergamo, Italy)

SAT12.06 18:25 Closing remarks


11

Friday, 15 September 2017 SATELLITE SYMPOSIA

SAT13 Integritas Communications (HCP only)

Looking Beneath the Surface in Atopic Dermatitis:

Targeting Immune Dysregulation and Delivering

Comprehensive Care

17:00-18:30 Room 2

SAT13.01 17:00 Atopic Dermatitis Pathogenesis

Jeffrey M. Weinberg (New York, USA)

SAT13.02 17:30 Comprehensive Patient Assessment

Michael J. Cork (Sheffield, United Kingdom)

SAT13.03 18:00 Management of Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson (Oregon, USA)

SAT14 PeerVoice (HCP only)

Meet the Experts: A Discussion on Best Approaches for

Your Challenging Hidradenitis Suppurativa Cases

17:00-18:30 Room 3

Chair: Hessel H. van der Zee (Rotterdam, the Netherlands)

SAT14.01 17:00 Welcome and Introduction

Hessel H. van der Zee (Rotterdam, the Netherlands)

SAT14.02 17:10 Implementing Guidelines and Algorithms in HS

Brian Kirby (Dublin, Ireland)

SAT14.03 17:35 Combined Approaches in Treating HS

Maurizio Podda (Darmstadt, Germany)

SAT14.04 18:00 Managing Your Most Challenging HS Patients: Cases from the

Audience


Brian Kirby (Dublin, Ireland)

Maurizio Podda (Darmstadt, Germany)

SAT14.05 18:15 “Ask the Faculty” and Concluding Remarks


12


SAT15 LEO Pharma (HCP only)

Advancing Science: Driving Progress Today For a Clearer

Tomorrow

17:00-18:30 Room 4

Chair: Kristian Reich (Hamburg, Germany)



SAT15.02 17:10 New treatments - new data: re-thinking future treatment goals


SAT15.03 17:25 Beyond the skin - a broader view on disease facets

Caitriona Ryan (Dublin, Ireland)

SAT15.04 17:50 Which drug for which patient? The question of patient profiling

Hervé Bachelez (Paris, France)

SAT15.05 18:05 Panel Discussion

All

SAT15.06 18:25 Close


SAT16 Sandoz (HCP only)

Tackling the inflammatory burden of psoriasis: a

multidisciplinary approach

17:00-18:30 Room E

Chair: Giampiero Girolomoni (Verona, Italy)

SAT16.01 17:00 Welcome and introductions


SAT16.02 17:05 Current treatment landscape in moderate-to-severe psoriasis


SAT16.03 17:20 An update on the cardiometabolic comorbidities of psoriasis

Naveed Sattar (Glasgow, United Kingdom)

SAT16.04 17:40 Understanding the rheumatic comorbidities of psoriasis

Frank Behrens (Frankfurt, Germany)

SAT16.05 18:00 The link between the skin and the gut: inflammatory bowel

disease in patients with psoriasis

Krisztina Gecse (Amsterdam, The Netherlands)

SAT16.06 18:20 Panel discussion: a multidisciplinary approach to managing

comorbidities in psoriasis

Moderated by Giampiero Girolomoni, joined by all

13


SAT17 International Psoriasis Council (HCP only)

Advances in Psoriasis: A Focus on Emerging

Therapies and Approaches to Treatment

17:00-18:30 Room F

SAT17.01 17:00 Welcome and Overview

Peter van de Kerkhof (Nijmegen, The Netherlands)

SAT17.02 17:05 Current biologics available: To what extent are we

satisfied?

Mark Lebwohl (New York, USA)

SAT17.03 17:30 New Psoriasis therapies in development: Targeting the

IL-23 pathway and others

Claudia de la Cruz (Santiago, Chile)

SAT17.04 17:55 Psoriasis management techniques: A patient centered

approach


SAT17.05 18:20 Closing Comments


SAT18 Clinique (Open to all)

Innovation in Vitamin C

17:00-18:30 Room G

SAT18.01 17:00 News in Ageing Science

Tom Mammone (Melville, USA)

SAT18.02 17:30 Interest of a Vitamin C booster to deliver maximum result

Janet Pardo (New York, USA)

SAT18.03 18:00 Evaluation of a new way to use Vitamin C in ageing

Martina Kerscher (Hamburg, Germany)

14


SAT19 epgonline.org (HCP only)

Putting patients first - from presentation to practice in

CSU

17:00-18:30 Room K

Chair Marcus Maurer (Berlin, Germany)

SAT19.01 17:00 Welcome address

Marcus Maurer (Berlin, Germany)

SAT19.02 17:05 CSU in primary care - getting it right first time

Dermot Ryan (Kegworth, United Kingdom)

SAT19.04 17:25 More than hives - CSU and its common comorbidities

Pavel Kolkhir (Moscow, Russia)

Petra Staubach (Mainz, Germany)

SAT19.05 18:05 Updating best practice in the management of CSU

Marcus Maurer (Berlin, Germany)

SAT20 Medscape Education (HCP only)

Targeting Inflammation: Managing Comorbidity in

Psoriasis

17:00-18:30 Room V

SAT20.01 17:00 Welcome and Introductions


SAT20.02 17:05 Comorbidity in Psoriasis: An Overview


SAT20.03 17:15 Systemic Inflammation and Immunopathogenesis of

Comorbidity in Psoriasis

Ole Ahlehoff (Odense, Denmark)

SAT20.04 17:25 Screening for Comorbidity in Daily Clinical Practice


SAT20.05 17:40 Best Practice in the Holistic Management of Patients With

Psoriasis and Comorbidity: Challenges and Opportunities

Jo Lambert (Ghent, Belgium)

SAT20.06 18:00 Audience Q&A and Panel Discussion

SAT20.07 18:25 Program Conclusion


15


SAT21 Janssen PEARLS (HCP only)

From registry data to real-life experiences: A holistic

perspective of psoriasis treatment

17:00-18:30 Room W

Chairs: Robert Gniadecki (Copenhagen, Denmark)

Lluís Puig (Barcelona, Spain)



SAT21.02 17:05 Interpreting long-term registry data in the treatment of psoriasis

Richard Warren (Salford, United Kingdom)

SAT21.03 17:25 Real-life experiences and clinical cases: an interactive discussion


Robert Gniadecki (Copenhagen, Denmark)

SAT21.04 18:20 Conclusions and closing remarks

Robert Gniadecki (Copenhagen, Denmark)

SAT22 Almirall (HCP only)

The Changing Landscape of Psoriasis : New Horizons for

Biological Therapies

17:00-18:30 Room X

Chair: Christopher E.M. Griffiths (Manchester, United Kingdom)

SAT22.01 17:00 Welcome & Introductions

Christopher E.M. Griffiths (Manchester, United Kingdom)

SAT22.02 17:05 Biologic treatments for psoriasis: A translational medicine success

story


SAT22.03 17:20 The importance of the IL-23/Th17 pathway in the pathogenesis

and treatment of the disease


SAT22.04 17:45 The efficacy and safety of targeted IL-23 inhibition: Results of the

reSURFACE trials


SAT22.05 18:10 Round table: Panel discussion, Q&A




SAT22.06 18:25 Closing remarks


16

Thursday, 14 September 2017

MEET-THE-EXPERT

MTE01 Jett Cosmetics&Jett Medical (Open to all)

Non-invasive blepharoplasty with Jett Plasma Lift Medical

17:00-18:00 Room U

MTE01.01 17:00 Non-invasive blepharoplasty with Jett Plasma Lift Medical

Matus Baran (Brno, Czech Republic)

MTE01.02 17:30 Non-invasive blepharoplasty with Jett Plasma Lift Medical

Veronika Flasarova (Brno, Czech Republic)

MTE02 Fotona Medical Lasers (Open to all)

„Walking on stars“ with latest Q-Switched Laser

Technology

17:00-18:00 Room S

MTE02.01 17:00 Official Launching of Star Walker MaQX in Switzerland

Leonardo Marini (Trieste, Italy)

MTE07 LEO Pharma South Asia (HCP only)

Real clinical practise of topical treatment of psoriasis

17:00-18:00 Room T

MTE07.01 17:00 Are we underestimating the psoriasis patient's burden?


MTE08 Japan Bio Products co., ltd (Open to all)

“Power of Human Placenta Extracts in Dermatology space” -

case reports from treatment of psoriasis to chronic wounds

17:00-18:00 Room R

MTE08.01 17:00 Physiological effect repair booster Curacen essence

Gabriel Flores (Valencia, Spain)

MTE08.02 17:15 Human Placenta Extracts in Dermatological Diseases

Vicenta Llorca (Valencia, Spain)

17

Friday, 15 September 2017 MEET-THE-EXPERT

MTE03 Cynosure (Open to all)

Treatments That Enhance Patient Results and Grow Your

Practice ROI

17:00-18:00 Room U

MTE03.01 17:00 Grow and Expand Your Practice with SculpSure and PicoSure

Klaus Hoffmann (Bochum, Germany)

Christine Dierickx (Boom, Belgium)

Maurice Adatto (Geneva, Switzerland)

MTE04 LEO Pharma South Asia (HCP only)

Getting Under the Skin of Atopic Dermatitis

17:00-18:00 Room T

MTE04.01 17:00 Getting Under the Skin of Atopic Dermatitis

Christian Vestegaard (Aarhus, Denmark)

MTE04.02 17:45 Discussion, Q&A

MTE05 Celgene (HCP only)

Psoriasis in practice: Achieving broad clinical benefits

17:00-18:00 Room S

MTE05.01 17:00 Psoriasis in practice: Achieving broad clinical benefits

Dimitris Rigopoulos (Athens, Greece)

MTE05.02 17:20 Audience Q&A

MTE06 CoolSculpting (Open to all)

The Cryolipolysis evolution over the last 10 years

17:00-18:00 Room R

MTE06.01 17:00 The Cryolipolysis evolution over the last 10 years

Heidi A. Waldorf (New York, USA)

industry session programmes - geneva 2017 · industry session programmes 26th eadv congress . 2...

Documents